RetroSearch Browse

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from http://www.ncbi.nlm.nih.gov/pubmed/32211816 below:

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China Shaobo Shi^{1 2 3}, Bo Shen^{1 2 3}, Yuli Cai⁵, Tao Liu^{1 2 3}, Fan Yang⁶, Wei Gong⁷, Xu Liu⁴, Jinjun Liang^{1 2 3}, Qinyan Zhao^{1 2 3}, He Huang^{1 2 3}, Bo Yang^{1 2 3}, Congxin Huang^{1 2 3}

Affiliations

¹ Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
² Cardiovascular Research Institute, Wuhan University, Wuhan, China.
³ Hubei Key Laboratory of Cardiology, Wuhan University, Wuhan, China.
⁴ Shanghai Chest Hospital, Department of Cardiology, Shanghai Jiaotong University, Shanghai, China.
⁵ Department of Endocrinology, Renmin Hospital of Wuhan University, Wuhan, China.
⁶ Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, China.
⁷ Department of Radiology, Renmin Hospital of Wuhan University, Wuhan, China.

PMID: 32211816
PMCID: PMC7097841
DOI: 10.1001/jamacardio.2020.0950

Item in Clipboard

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

Shaobo Shi et al. JAMA Cardiol. 2020.

. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950. Authors Shaobo Shi^{1 2 3}, Mu Qin⁴, Bo Shen^{1 2 3}, Yuli Cai⁵, Tao Liu^{1 2 3}, Fan Yang⁶, Wei Gong⁷, Xu Liu⁴, Jinjun Liang^{1 2 3}, Qinyan Zhao^{1 2 3}, He Huang^{1 2 3}, Bo Yang^{1 2 3}, Congxin Huang^{1 2 3} Affiliations

¹ Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
² Cardiovascular Research Institute, Wuhan University, Wuhan, China.
³ Hubei Key Laboratory of Cardiology, Wuhan University, Wuhan, China.
⁴ Shanghai Chest Hospital, Department of Cardiology, Shanghai Jiaotong University, Shanghai, China.
⁵ Department of Endocrinology, Renmin Hospital of Wuhan University, Wuhan, China.
⁶ Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, China.
⁷ Department of Radiology, Renmin Hospital of Wuhan University, Wuhan, China.

PMID: 32211816
PMCID: PMC7097841
DOI: 10.1001/jamacardio.2020.0950

Item in Clipboard

Abstract

Importance: Coronavirus disease 2019 (COVID-19) has resulted in considerable morbidity and mortality worldwide since December 2019. However, information on cardiac injury in patients affected by COVID-19 is limited.

Objective: To explore the association between cardiac injury and mortality in patients with COVID-19.

Design, setting, and participants: This cohort study was conducted from January 20, 2020, to February 10, 2020, in a single center at Renmin Hospital of Wuhan University, Wuhan, China; the final date of follow-up was February 15, 2020. All consecutive inpatients with laboratory-confirmed COVID-19 were included in this study.

Main outcomes and measures: Clinical laboratory, radiological, and treatment data were collected and analyzed. Outcomes of patients with and without cardiac injury were compared. The association between cardiac injury and mortality was analyzed.

Results: A total of 416 hospitalized patients with COVID-19 were included in the final analysis; the median age was 64 years (range, 21-95 years), and 211 (50.7%) were female. Common symptoms included fever (334 patients [80.3%]), cough (144 [34.6%]), and shortness of breath (117 [28.1%]). A total of 82 patients (19.7%) had cardiac injury, and compared with patients without cardiac injury, these patients were older (median [range] age, 74 [34-95] vs 60 [21-90] years; P < .001); had more comorbidities (eg, hypertension in 49 of 82 [59.8%] vs 78 of 334 [23.4%]; P < .001); had higher leukocyte counts (median [interquartile range (IQR)], 9400 [6900-13 800] vs 5500 [4200-7400] cells/μL) and levels of C-reactive protein (median [IQR], 10.2 [6.4-17.0] vs 3.7 [1.0-7.3] mg/dL), procalcitonin (median [IQR], 0.27 [0.10-1.22] vs 0.06 [0.03-0.10] ng/mL), creatinine kinase-myocardial band (median [IQR], 3.2 [1.8-6.2] vs 0.9 [0.6-1.3] ng/mL), myohemoglobin (median [IQR], 128 [68-305] vs 39 [27-65] μg/L), high-sensitivity troponin I (median [IQR], 0.19 [0.08-1.12] vs <0.006 [<0.006-0.009] μg/L), N-terminal pro-B-type natriuretic peptide (median [IQR], 1689 [698-3327] vs 139 [51-335] pg/mL), aspartate aminotransferase (median [IQR], 40 [27-60] vs 29 [21-40] U/L), and creatinine (median [IQR], 1.15 [0.72-1.92] vs 0.64 [0.54-0.78] mg/dL); and had a higher proportion of multiple mottling and ground-glass opacity in radiographic findings (53 of 82 patients [64.6%] vs 15 of 334 patients [4.5%]). Greater proportions of patients with cardiac injury required noninvasive mechanical ventilation (38 of 82 [46.3%] vs 13 of 334 [3.9%]; P < .001) or invasive mechanical ventilation (18 of 82 [22.0%] vs 14 of 334 [4.2%]; P < .001) than those without cardiac injury. Complications were more common in patients with cardiac injury than those without cardiac injury and included acute respiratory distress syndrome (48 of 82 [58.5%] vs 49 of 334 [14.7%]; P < .001), acute kidney injury (7 of 82 [8.5%] vs 1 of 334 [0.3%]; P < .001), electrolyte disturbances (13 of 82 [15.9%] vs 17 of 334 [5.1%]; P = .003), hypoproteinemia (11 of 82 [13.4%] vs 16 of 334 [4.8%]; P = .01), and coagulation disorders (6 of 82 [7.3%] vs 6 of 334 [1.8%]; P = .02). Patients with cardiac injury had higher mortality than those without cardiac injury (42 of 82 [51.2%] vs 15 of 334 [4.5%]; P < .001). In a Cox regression model, patients with vs those without cardiac injury were at a higher risk of death, both during the time from symptom onset (hazard ratio, 4.26 [95% CI, 1.92-9.49]) and from admission to end point (hazard ratio, 3.41 [95% CI, 1.62-7.16]).

Conclusions and relevance: Cardiac injury is a common condition among hospitalized patients with COVID-19 in Wuhan, China, and it is associated with higher risk of in-hospital mortality.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures
Figure 1.. Flowchart of Patient Recruitment

Figure 1.. Flowchart of Patient Recruitment
Figure 1.. Flowchart of Patient Recruitment
Figure 2.. Mortality During Hospitalization Between Patients…

Figure 2.. Mortality During Hospitalization Between Patients With vs Without Cardiac Injury

A-B, Kaplan-Meier survival…

Figure 2.. Mortality During Hospitalization Between Patients With vs Without Cardiac Injury

A-B, Kaplan-Meier survival curves for mortality during the time from symptom onset (A) and admission (B). In (B), the maximum duration was 16 days. C, Patients with cardiac injury had a higher rate of mortality in log-rank test, both from symptom onset and from admission.

Comment in

Will Complement Inhibition Be the New Target in Treating COVID-19-Related Systemic Thrombosis?
Campbell CM, Kahwash R. Campbell CM, et al. Circulation. 2020 Jun 2;141(22):1739-1741. doi: 10.1161/CIRCULATIONAHA.120.047419. Epub 2020 Apr 9. Circulation. 2020. PMID: 32271624 No abstract available.
Elevated Cardiac Troponin I Is Associated with Poor Outcomes in COVID-19 Patients at an Academic Medical Center in Midwestern USA.
Franks CE, Scott MG, Farnsworth CW. Franks CE, et al. J Appl Lab Med. 2020 Sep 1;5(5):1137-1139. doi: 10.1093/jalm/jfaa092. J Appl Lab Med. 2020. PMID: 32484893 Free PMC article. No abstract available.
Spontaneous Coronary Artery Dissection in a Patient With COVID-19.
Courand PY, Harbaoui B, Bonnet M, Lantelme P. Courand PY, et al. JACC Cardiovasc Interv. 2020 Jun 22;13(12):e107-e108. doi: 10.1016/j.jcin.2020.04.006. Epub 2020 Apr 8. JACC Cardiovasc Interv. 2020. PMID: 32553344 Free PMC article. No abstract available.
Coronavirus Disease 2019 (COVID-19) and Cardiac Injury.
Heffernan KS, Michos ED, Gump BB. Heffernan KS, et al. JAMA Cardiol. 2020 Oct 1;5(10):1198. doi: 10.1001/jamacardio.2020.2450. JAMA Cardiol. 2020. PMID: 32639510 No abstract available.
Coronavirus Disease 2019 (COVID-19) and Cardiac Injury.
Meyer P, Ghadri JR, Templin C. Meyer P, et al. JAMA Cardiol. 2020 Oct 1;5(10):1198-1199. doi: 10.1001/jamacardio.2020.2453. JAMA Cardiol. 2020. PMID: 32639523 No abstract available.
Myocardial edema in COVID-19 on cardiac MRI.
Manka R, Karolyi M, Polacin M, Holy EW, Nemeth J, Steiger P, Schuepbach RA, Zinkernagel AS, Alkadhi H, Mehra MR, Ruschitzka F. Manka R, et al. J Heart Lung Transplant. 2020 Jul;39(7):730-732. doi: 10.1016/j.healun.2020.04.025. Epub 2020 May 28. J Heart Lung Transplant. 2020. PMID: 32650881 Free PMC article. No abstract available.